Lucile Vanhersecke

928 total citations · 1 hit paper
17 papers, 133 citations indexed

About

Lucile Vanhersecke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Lucile Vanhersecke has authored 17 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Lucile Vanhersecke's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (5 papers) and Immunotherapy and Immune Responses (3 papers). Lucile Vanhersecke is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (5 papers) and Immunotherapy and Immune Responses (3 papers). Lucile Vanhersecke collaborates with scholars based in France, United States and Malaysia. Lucile Vanhersecke's co-authors include Antoîne Italiano, Alban Bessede, Maxime Brunet, Florent Peyraud, François Le Loarer, Jean‐Philippe Guégan, Valérie Velasco, Christophe Rey, Jean‐Michel Coindre and Carine Bellera and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Lucile Vanhersecke

15 papers receiving 133 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

2025 18 citations Florent Peyraud, Lucile Vanhersecke et al. Cell Reports Medicine profile →

Peers

Lucile Vanhersecke

ONCOL

IMMUN

PRM

Hongqian Wu United States

Yiman Shang China

Marie Naigeon France

Shaun Tiwari United States

Karim Amrane France

Miya Haruna Japan

Nicholas Venturini United States

Rachel Roberts‐Thomson Australia

Nicole Fuhrich Germany

Marc‐Olivier Sauvain Switzerland

Hongqian Wu United States

Lucile Vanhersecke

93 ×0.9

ONCOL

29 ×0.5

IMMUN

28 ×0.7

PRM

22 ×1.2

7 ×0.7

Citations per year, relative to Lucile Vanhersecke Lucile Vanhersecke (= 1×) peers Hongqian Wu

Countries citing papers authored by Lucile Vanhersecke

Since Specialization

Citations

This map shows the geographic impact of Lucile Vanhersecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucile Vanhersecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucile Vanhersecke more than expected).

Fields of papers citing papers by Lucile Vanhersecke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucile Vanhersecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucile Vanhersecke. The network helps show where Lucile Vanhersecke may publish in the future.

Co-authorship network of co-authors of Lucile Vanhersecke

This figure shows the co-authorship network connecting the top 25 collaborators of Lucile Vanhersecke. A scholar is included among the top collaborators of Lucile Vanhersecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucile Vanhersecke. Lucile Vanhersecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hernández-Verdín, Isaias, et al.. (2026). Tertiary lymphoid structures in the era of cancer therapy. Journal of Experimental & Clinical Cancer Research. 45(1). 48–48.

Michot, Audrey, Jean‐Michel Coindre, Valérie Velasco, et al.. (2025). Prognostic prediction in soft-tissue sarcomas using deep learning and digital pathology of tumor and margin areas. Scientific Reports. 15(1). 38534–38534.

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2025). Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside. Med. 6(1). 100546–100546. 13 indexed citations

Toulmonde, Maud, Mariella Spalato Ceruso, Thibaud Valentin, et al.. (2025). Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab. Signal Transduction and Targeted Therapy. 10(1). 202–202. 2 indexed citations

Peyraud, Florent, Lucile Vanhersecke, Jean‐Michel Coindre, et al.. (2025). Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures. Cell Reports Medicine. 6(2). 101934–101934. 18 indexed citations breakdown →

Cousin, Sophie, Jean‐Philippe Guégan, Lola‐Jade Palmieri, et al.. (2025). Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis. Nature Cancer. 6(4). 584–594. 4 indexed citations

Debien, Véronique, Alexandre Moreau, Florent Peyraud, et al.. (2024). 84P Advancing precision oncology: Integrating immune landscape and genomics for tailored therapy in metastatic cancer patients. Annals of Oncology. 35. S248–S248. 1 indexed citations

Vanhersecke, Lucile, Pierre Jacob, Ludovic Gillet, et al.. (2024). 1779P Deep learning tertiary lymphoid structures detection on HES/H&E slides and association to survival outcome in sarcoma. Annals of Oncology. 35. S1058–S1058. 1 indexed citations

Italiano, Antoîne, Sophie Cousin, Carine Bellera, et al.. (2024). Abstract CT033: Avelumab combined with regorafenib in solid tumors with tertiary lymphoid structures: A phase 2 REGOMUNE trial cohort. Cancer Research. 84(7_Supplement). CT033–CT033. 3 indexed citations

10.

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2024). Abstract 7471: Cancer-associated fibroblasts drive T cell infiltration and resistance to immunotherapy in non-small cell lung cancer with mature tertiary lymphoid structures. Cancer Research. 84(6_Supplement). 7471–7471. 1 indexed citations

11.

Vanhersecke, Lucile, Antoine Bougoüin, Amandine Crombé, et al.. (2023). Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers. Laboratory Investigation. 103(5). 100063–100063. 49 indexed citations

12.

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2023). Abstract 6767: Cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures. Cancer Research. 83(7_Supplement). 6767–6767. 1 indexed citations

13.

Brunet, Maxime, et al.. (2023). Abstract 2361: Prevalence of mature tertiary lymphoid structures and association with tumor mutational burden in patients with solid tumors. Cancer Research. 83(7_Supplement). 2361–2361. 2 indexed citations

14.

Michal, Michael, Lucile Vanhersecke, Jean‐Michel Coindre, et al.. (2023). PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 145–156. 15 indexed citations

15.

Bessede, Alban, Florent Peyraud, Benjamin Besse, et al.. (2023). TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 30(4). 779–785. 20 indexed citations

16.

Italiano, Antoîne, Laura Leroy, Jean‐Philippe Guégan, et al.. (2023). TROP2 expression and response to immune checkpoint inhibition in patients with advanced non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 9040–9040. 2 indexed citations

17.

Vanhersecke, Lucile, et al.. (2022). 10P Deep learning-based prediction of patient’s TLS status from HE images in pan-cancer cohort. Immuno-Oncology Technology. 16. 100115–100115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact